BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 19886737)

  • 1. Regulation of Th-POK and Runx3 in T cell development in human thymoma.
    Tokunaga T; Hayashi A; Kadota Y; Shiono H; Inoue M; Sawabata N; Okumura M
    Autoimmunity; 2009; 42(8):653-60. PubMed ID: 19886737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reciprocal control of G1-phase progression is required for Th-POK/Runx3-mediated CD4/8 thymocyte cell fate decision.
    Sato T; Chiba T; Ohno S; Sato C; Sugoh T; Miyashita K; Akatsuka H; Hozumi K; Okada Y; Iida Y; Akatsuka A; Agata Y; Chiba M; Kohu K; Satake M; Tanabe H; Saya H; Habu S
    J Immunol; 2012 Nov; 189(9):4426-36. PubMed ID: 23018457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repression of the transcription factor Th-POK by Runx complexes in cytotoxic T cell development.
    Setoguchi R; Tachibana M; Naoe Y; Muroi S; Akiyama K; Tezuka C; Okuda T; Taniuchi I
    Science; 2008 Feb; 319(5864):822-5. PubMed ID: 18258917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The zinc finger transcription factor Th-POK regulates CD4 versus CD8 T-cell lineage commitment.
    He X; He X; Dave VP; Zhang Y; Hua X; Nicolas E; Xu W; Roe BA; Kappes DJ
    Nature; 2005 Feb; 433(7028):826-33. PubMed ID: 15729333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the transcription factor Th-POK in CD4:CD8 lineage commitment.
    Kappes DJ; He X; He X
    Immunol Rev; 2006 Feb; 209():237-52. PubMed ID: 16448546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell development in human thymoma.
    Inoue M; Fujii Y; Okumura M; Miyoshi S; Shiono H; Fukuhara K; Kadota Y; Matsuda H
    Pathol Res Pract; 1999; 195(8):541-7. PubMed ID: 10483584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of immature CD3-CD4+CD8- single-positive cells that lack CD69 in epithelial cell tumors of the human thymus.
    Takeuchi Y; Fujii Y; Okumura M; Inada K; Nakahara K; Matsuda H
    Cell Immunol; 1995 Apr; 161(2):181-7. PubMed ID: 7697728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposite CD4/CD8 lineage decisions of CD4+8+ mouse and rat thymocytes to equivalent triggering signals: correlation with thymic expression of a truncated CD8 alpha chain in mice but not rats.
    Mitnacht R; Bischof A; Torres-Nagel N; Hünig T
    J Immunol; 1998 Jan; 160(2):700-7. PubMed ID: 9551905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Runx3 regulates integrin alpha E/CD103 and CD4 expression during development of CD4-/CD8+ T cells.
    Grueter B; Petter M; Egawa T; Laule-Kilian K; Aldrian CJ; Wuerch A; Ludwig Y; Fukuyama H; Wardemann H; Waldschuetz R; Möröy T; Taniuchi I; Steimle V; Littman DR; Ehlers M
    J Immunol; 2005 Aug; 175(3):1694-705. PubMed ID: 16034110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon regulatory factor 4 regulates thymocyte differentiation by repressing Runx3 expression.
    Cao Y; Li H; Sun Y; Chen X; Liu H; Gao X; Liu X
    Eur J Immunol; 2010 Nov; 40(11):3198-209. PubMed ID: 21061442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human thymocytes become lineage committed at an early postselection CD69+ stage, before the onset of functional maturation.
    Vanhecke D; Verhasselt B; De Smedt M; Leclercq G; Plum J; Vandekerckhove B
    J Immunol; 1997 Dec; 159(12):5973-83. PubMed ID: 9550395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of the Runx3 transcription factor increases the proportion of mature thymocytes of the CD8 single-positive lineage.
    Kohu K; Sato T; Ohno S; Hayashi K; Uchino R; Abe N; Nakazato M; Yoshida N; Kikuchi T; Iwakura Y; Inoue Y; Watanabe T; Habu S; Satake M
    J Immunol; 2005 Mar; 174(5):2627-36. PubMed ID: 15728469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+ T cells mature in the absence of MHC class I and class II expression in Ly-6A.2 transgenic mice.
    Henderson SC; Berezovskaya A; English A; Palliser D; Rock KL; Bamezai A
    J Immunol; 1998 Jul; 161(1):175-82. PubMed ID: 9647222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p300-mediated acetylation stabilizes the Th-inducing POK factor.
    Zhang M; Zhang J; Rui J; Liu X
    J Immunol; 2010 Oct; 185(7):3960-9. PubMed ID: 20810990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro induction of CD8 expression on thymic pre-T cells. I. Transforming growth factor-beta and tumor necrosis factor-alpha induce CD8 expression on CD8- thymic subsets including the CD25+CD3-CD4-CD8- pre-T cell subset.
    Suda T; Zlotnik A
    J Immunol; 1992 Mar; 148(6):1737-45. PubMed ID: 1347307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonistic interplay between ThPOK and Runx in lineage choice of thymocytes.
    Egawa T; Taniuchi I
    Blood Cells Mol Dis; 2009; 43(1):27-9. PubMed ID: 19375362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. bcl-2 proto-oncogene expression during human T cell development. Evidence for biphasic regulation.
    Gratiot-Deans J; Ding L; Turka LA; Nuñez G
    J Immunol; 1993 Jul; 151(1):83-91. PubMed ID: 8326141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Runx3 and Runx1 are required for CD8 T cell development during thymopoiesis.
    Woolf E; Xiao C; Fainaru O; Lotem J; Rosen D; Negreanu V; Bernstein Y; Goldenberg D; Brenner O; Berke G; Levanon D; Groner Y
    Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7731-6. PubMed ID: 12796513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-color flow cytometric study on lymphocytes derived from thymic diseases.
    Okumura M; Fujii Y; Miyoshi S; Shiono H; Inoue M; Kadota Y; Fukuhara K; Matsuda H
    J Surg Res; 2001 Dec; 101(2):130-7. PubMed ID: 11735267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual functions of Runx proteins for reactivating CD8 and silencing CD4 at the commitment process into CD8 thymocytes.
    Sato T; Ohno S; Hayashi T; Sato C; Kohu K; Satake M; Habu S
    Immunity; 2005 Mar; 22(3):317-28. PubMed ID: 15780989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.